Regulatory/Legislative News

SAN FRANCISCO — Improved technologies and advanced techniques have given corneal laser surgery a valuable role in therapeutic treatment, according to a presentation here.

The FDA has issued warning letters to eight companies for manufacturing or marketing unapproved ophthalmic drug products, the agency announced in a press release.

The FDA has issued a warning to consumers not to purchase and to immediately stop use of Dr. Berne’s MSM Drops 5% Solution and LightEyez MSM Eye Drops because of bacterial and fungal contamination.

WASHINGTON — Optometrists must learn about myopia management and discuss it with parents, according to clinicians participating in a panel discussion at Optometry’s Meeting.

On Aug. 4 New Hampshire Gov. Chris Sununu signed into a law a bill that grants optometrists in the state authority to administer vaccines to their patients, according to the American Optometric Association website.

Illinois and Georgia have passed legislation to protect optometrists from vision plan-enforced discounts and interference in the doctor-patient relationship.

House Committee on Oversight and Accountability Chairman James Comer requested that the Federal Trade Commission hold a staff-level briefing to discuss the impact of vision care market consolidation on consumers.

Florida Gov. Ron DeSantis today vetoed Senate Bill 230, which would have prohibited a doctor of optometry from using the term “optometric physician” and made it a felony to do so.

A proposed bill to make ordering contact lenses online safer by banning sellers from verifying prescriptions through robocalls has earned the praise of the Health Care Alliance for Patient Safety.

The FDA has approved Eyenovia’s Mydcombi ophthalmic spray for inducing mydriasis, the company announced in a press release.